treatment of alcoholic liver disease. This has included strategies to increase abstinence from alcohol, the effects of nutritional supplementation, pharmacological methods of modifying the disease process and other hepatoprotective agents. Together with Roy Calne in Cambridge the Liver Unit pioneered liver transplantation in Britain and more recently, this method of treatment has been offered to a number of patients with end-stage alcoholic liver damage.
The study of alcoholic liver disease has therefore come of age. The Liver Unit's research programme has developed in response to the increasing problems caused by alcohol in this country. It has evolved logically, using techniques developed for investigating other forms of liver disease, and with an emphasis on collaboration with other units to provide a true multidisciplinary perspective.
Mechanisms of liver damage IMMUNOLOGICAL INJURY
The possibility that alcoholic liver disease might be in part, the result of an 'immune attack' on hepatocytes is suggested by the histological features of alcoholic hepatitis with infiltration of polymorphonuclear and mononuclear cells, and the observation that in some patients progression of the hepatic injury occurred even after abstinence. In severe alcoholic hepatitis especially, liver damage often increases for two to four weeks after admission to hospital and after cessation of alcohol consumption. To determine whether an autoimmune reaction to liver specific proteins was occurring, Cochrae and colleagues7 adopted the lymphocytotoxicity assay of Thomson et al. 4 Lymphocyte toxicity towards normal (rabbit) hepatocytes was shown in 15 of 17 patients with alcoholic hepatitis, and was not present at other stages of alcoholic liver disease. It was possible to block this reaction by the addition of a liver specific protein extracted from the membrane of liver cells, lending support to the view that the exposed protein was acting as an antigen. The probability that lymphocyte mediated toxicity could play an important role in hepatocyte injury in alcoholic hepatitis was further strengthened by the observation that the degree of cytotoxicity correlated well with the presence of liver cell necrosis. Furthermore, antibodies to liver specific protein could be detected in such patients, and correlated with the degree of necrosis. 8 In an extension of this work, Neuberger and colleagues showed the presence of circulating antibodies in 43% of patients with alcoholic liver disease which reacted specifically with hepatocytes isolated from ethanol pretreated rabbits. particularly when considering the evolution of this process in the patient. Although the direct toxic effect ofthe products ofalcohol metabolism is no longer questioned, there is evidence indicating that malnutrition may be needed to produce the spectrum of alcoholic liver damage seen.
In man, ethanol is largely metabolised by two systems: the alcohol dehydrogenase and MEOS pathways, the latter being induced by high levels ofalcohol intake. All pathways produce acetaldehyde as an intermediate product. This molecule is extremely reactive, combining with lysine or valine residues or with nucleic acids or peptides, and may produce immunologically foreign proteins or loss of enzyme activity causing the hepatocyte to become less efficient.
Acetaldehyde also reacts with tubulin, interfering with its polymerisation by binding covalently to its dimer form. This impedes the movement of organelles and proteins within the cell and the interference with hepatocyte cell membrane proteins is likely to impair protein transport across the cell surface membrane. These findings may explain why high ethanol intake causes accumulation of protein within the hepatocyte. Damage to microtubules or their associated proteins will interrupt protein transport, and membrane protein damage is consistent with the impairment of receptor mediated endocytosis of macromolecules in the liver in alcoholism. Defects in protein trafficking are likely to interfere with the function of many hormones, trophic factors, biogenic peptides, and carrier proteins. 16 The oxidation of acetaldehyde especially by the low Km acetaldehyde dehydrogenase will generate free radical oxygen species (Fig 3) . These molecules are highly reactive and are capable of damaging cells.
Studies into biochemical mechanisms of alcoholic liver injury started in 1980 with the establishment of techniques for assaying acetaldehyde, and the activities and isoenzyme profiles of the principal alcohol metabolising enzymes. Higher blood acetaldehyde concentrations were found after administration of alcohol in alcohol dependent subjects and those with liver damage than in healthy non-alcoholic controls.'7 Furthermore, hepatic aldehyde dehydrogenase activity was lower in patients with alcoholic cirrhosis than in those with fatty liver. This seems to be an acquired defect and suggests that patients with cirrhosis are particularly liable to accumulate acetaldehyde during metabolism of alcohol. They may experience a vicious circle of increasing acetaldehyde concentrations, causing greater liver injury, which further suppresses aldehyde dehydrogenase activity. '8 As described previously, alcohol, and specifically its metabolite acetaldehyde, have been shown to result in the formation of neoantigens. These are presumably located on the surface of hepatocytes. To complement this work, the activities of surface membrane associated enzymes were studied. Alcohol was shown to suppress activities of (Na+-K+)ATPase in vitro. 1 ' Although the concentrations that produce this effect are generally higher than occur in man, these experiments serve to illustrate the multifaceted effects of alcohol and raise the possibility that in vivo acetaldehyde synthesised in proximity to surface membranes may inhibit enzyme and ion channel function at concentrations approximating to those occurring during the metabolism of alcohol.
Susceptibility to alcoholic liver disease EPIDEMIOLOGY Early epidemiological studies of alcoholic liver disease showed a dose response relationship between cumulative alcohol consumption and the risk of cirrhosis.20 In contrast, recent prospective studies have suggested that only about 20% of heavy drinkers will ultimately develop alcoholic cirrhosis, provided their average daily intake regularly exceeds a threshold dose of about 50-60 g.5 This is consistent with the common clinical experience that some individuals develop alcoholic cirrhosis while still in their early 20s while others escape damage after a lifetime of heavy drinking. Investigation of the basis for this differing susceptibility has been a major focus of research in the Liver Unit since the mid-1970s.
Individual variation in susceptibility could be partly explained by environmental factors, such as alteration of the metabolic handling of alcohol by exposure to enzyme inducing drugs, or concomitant infection with hepatitis viruses. It might reflect subtle differences in the pattern of drinking between individuals. It is also likely that genetic factors play a significant role. '8 Initial studies examined the influence of gender and histocompatibility antigen (HLA) status. In the first large clinical series reported from the Liver Unit, Krasner and colleagues2' showed that women were more likely to have alcoholic hepatitis at presentation than men; 91% of men had an average daily alcohol intake exceeding 150 g compared with 65% of women.
This substantial difference in susceptibility between the sexes was confirmed in a later series by Saunders and colleagues.22 23 The earlier report22 synthesised the published work on sex related differences, and showed that women developed alcoholic liver disease at a younger age, after a shorter period of drinking, and at a lower mean daily alcohol intake than men. They formulated three hypotheses: (i) differences in body composition, specifically the lower lean body mass and higher proportion of fatty tissue in women resulted in higher blood alcohol concentrations after a standard drink than in men, and accordingly more severe tissue injury; (ii) the greater propensity of women to develop autoimmune disorders predisposed them to develop a heightened immune response to normal liver cell components and to alcohol induced neoantigens (this might also be related to histocompatibility antigen factor status); (iii) that sex related differences in alcohol metabolising enzymes resulted in women having higher acetaldehyde concentrations and a greater risk of free radical injury.
The last hypothesis was more speculative, although alcohol dehydrogenase activity is higher in the females of certain animal species than in males. Rates of abstinence after discharge range from 4% to 30% in most series. To try to improve on this, investigations into psychiatric disorders and psychosocial impairment were instituted in 1980. Forty eight per cent of patients with alcoholic liver disease had a history of depressive disorder compared with 22% of patients with non-alcoholic liver disease of comparable severity.32 In women there was a two fold higher rate of neurotic disorders than in the nonalcoholic control group. These findings had a direct influence on the treatment of the underlying drinking behaviour. As well as receiving advice on abstinence and feedback of the results of the medical assessment, patients were screened for psychiatric problems. Referral was arranged for those who had such disorders and some of the therapies used in the Alcohol Problems Service at the Maudsley Hospital were adopted by the staff of the Alcohol Research Group. Although a controlled trial of this combined approach was not undertaken, abstinence rates ofup to 55% were achieved, with validation by monitoring of urine samples for the presence of alcohol.33
PHARMACOLOGICAL TREATMENT OF ALCOHOLIC LIVER DISEASE
The mortality from alcoholic liver disease in the first three months after admission to hospital varies between 22% for all histological categories of patient to 60% for those with severe alcoholic hepatitis. Specific forms of treatment for alcoholic liver disease have been evaluated in patients with alcoholic hepatitis in an attempt to decrease short term mortality and prevent progression to cirrhosis. In this area the Liver Unit has been particularly active.
The possibility that immune mechanisms play a role in the pathogenesis of alcoholic hepatitis encouraged controlled trials ofcorticosteroids on the basis of their immunosuppressant and antiinflammatory activity. The first study of corticosteroids in acute severe alcoholic hepatitis was reported by Helman and colleagues, who showed a statistically significant improvement in short term mortality with 40 mg/day prednisolone in 14 severely ill patients, all of whom had hepatic encephalopathy.34 In a controlled trial in the Liver Unit, 55 patients were randomised to receive either methylprednisolone 1 g daily for three days or placebo, on the basis that this dose of steroids was known to be effective in reversing acute rejection in renal and liver transplants. There was no significant difference, however, in mortality between the treatment and placebo groups, with 57% of the control group and 63% of the treatment group dying during the study .35 Interest in the use of steroids in the treatment of alcoholic hepatitis has continued and there have been 10 other randomised controlled trials in the last 20 years. A recent meta-analysis of the 11 trials containing sufficient information suggested that in the small subgroup of very ill patients with spontaneous hepatic encephalopathy, in whom sepsis is not present, steroids could be of significant benefit. 36 Among other specific therapies for alcoholic hepatitis, the use of nutritional supplements has been proposed on the basis that nutritional deficiencies may promote the toxic effects of alcohol by the depletion of amino acids and enzymes. 37 Evidence for this comes from a large Veterans Administration study in which all patients with alcoholic hepatitis had evidence of protein-calorie malnutrition and in which the severity of liver injury correlated with the degree of malnutrition. Rehabilitation, as defined by a return to occupational and social functioning was evident in 17 of the 18 patients who survived at least three months. Three patients were suspected of relapsing to heavy drinking within six months after transplant. Although they did not admit to taking alcohol, there was corroborative evidence of a return to drinking shown by rises in mean cell volume and a raised gammaglutamyl transferase to alkaline phosphatase ratio. In one of these patients, liver histology two years after transplant showed alcoholic hyaline, fatty change, and advanced fibrosis, highly suggestive of alcohol induced damage. It is of considerable interest that this patient is positive for histocompatibility antigen factor B8, which was linked to earlier work showing a more rapid development of cirrhosis.23 As the graft was of a completely different histocompatibility antigen factor type, this could be evidence that the vulnerability of the liver to alcohol in an histocompatibility antigen factor B8 positive individual is secondary to host factors rather than to characteristics intrinsic to the liver. The three patients who returned to harmful drinking were the only ones not abstinent before transplant.
Analysis of the indications for transplantation reveals some differences in the selection criteria used by British and American groups. In the Cambridge and King's College Hospital series, all except three patients were abstinent for at least six months at the time of transplantation and therefore fulfilled the criteria of the National Institute of Health Consensus Conference." In the recent report on liver transplantation in alcoholic liver disease from Pittsburgh, patients were selected on the basis of their 'urgency of need' as assessed by the severity of the patient's medical condition, and a minimum period of abstinence was not required. 45 Of the 73 patients in the Pittsburgh series, none have returned to harmful drinking after transplantation, although follow up was conducted by telephone survey only, and a comparison of mean cell volume and serum enzyme activities, which could have pointed to harmful drinking, was not made.46 In contrast to the American study, our results suggest that liver transplantation should not be considered as a treatment for alcohol dependence in itself, and the criteria for selecting patients under normal circumstances should include a period of abstinence of at least six months.
Conclusion
Research in the Liver Unit during the past 25 years has been at the forefront of intellectual endeavour. Major contributions in the field of alcoholic liver disease include studies of immunological mechanisms to determine why some patients are more susceptible to aggressive liver damage at a cellular level. There has been considerable effort devoted to identify groups of susceptible individuals and, in particular, there has been the recognition that women, those with the histocompatibility antigen factor B8 antigen and with an unremitting pattern of daily drinking are at particular risk. The Liver Unit has undertaken many studies to find substances which would ameliorate the outcome of alcoholic hepatitis and it is unfortunate that success has been elusive. The extensive expertise in liver transplantation, however, now available to patients with alcoholic liver disease, will no doubt contribute substantially in the future. Attempts to identify the significant steps in alcohol induced hepatocyte necrosis and the factors influencing aggressive histological deterioration in alcoholic liver disease have generated much work over the past quarter of a century. It is likely that alcoholic liver disease arises from an interplay between biochemical and immunological disturbances. There are several genetic and environmental factors, including malnutrition, which are important in determining the propensity to develop cirrhosis and these factors, together with their degree of influence, may vary at different stages of the disease process. Much work, therefore, remains to be done, but with new information, new techniques and a record of continued commitment, the Liver Unit is well placed to make important contributions in this area in the future.
